Isodiol International Inc. (ISOLF)

Market Cap	129.00
Revenue (ttm)	12.18M -18.3%
Net Income	-78.75M
EPS	-1.68
Shares Out	128.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,580
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	-185.13
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Isodiol International

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marcos Agramont
• Employees: 57
• Stock Exchange: OTCMKTS
• Ticker Symbol: ISOLF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error